Felipe Ribeiro Serzedello

Felipe Ribeiro Serzedello

Auto-generated profile, based on publicly available information

Felipe Ribeiro Serzedello

Universidade de São Paulo, Faculdade de Medicina, Instituto de Ortopedia e Traumatología, Hospital das Clínicas HCFMUSP, Hip Group, São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Acta Ortopedica Brasileira
Verified
Journal Article
Open access
PDF file
HMHelder de Souza Miyahara
Helder de Souza Miyahara
FSFelipe Ribeiro Serzedello
Felipe Ribeiro Serzedello
LELeandro Ejnisman
Leandro Ejnisman
ALAna Lúcia Lei Munhoz Lima
Ana Lúcia Lei Munhoz Lima
JVJosé Ricardo Negreiros Vicente
José Ricardo Negreiros Vicente
CHCamilo Partezani Helito
Camilo Partezani Helito
Objective: To present our institution's experience with negative-pressure wound therapy (NPWT) as an adjuvant in wound healing of patients who have undergone revision total hip arthroplasty (THA) due to septic loosening in the presence of active fistula. Methods: We prospectively assessed patients presenting with THA infection, associated with the presence of fistula, treated with a PICO® device for NPWT, in combination with the standard treatment for prosthesis infection in our institution. Resolution of the infectious process and healing of the surgical wound without complications were considered an initial favorable outcome. Results: We assessed 10 patients who used PICO® in our department. No complications were identified in association with the use of the NPWT device. The mean follow-up of the patients after use of the device was 12.7 months. Only one patient progressed with fistula reactivation and recurrence of infection. Conclusion: NPWT can be used in wound complications and infection following THA procedures safely and with promising results. Randomized prospective studies should be conducted to confirm its effectiveness. Level of Evidence IV, Case Series.